AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
15.54 USD
-0.21 (-1.33%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of AMN get a neutral evaluation. Nothing too spectacular is happening here. AMN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
AMN had positive earnings in 4 of the past 5 years.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
AMN's Return On Assets of -12.88% is on the low side compared to the rest of the industry. AMN is outperformed by 76.00% of its industry peers.
AMN has a worse Return On Equity (-42.76%) than 72.00% of its industry peers.
AMN has a Return On Invested Capital (2.08%) which is comparable to the rest of the industry.
AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.19%.
The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (1.65%) which is comparable to the rest of the industry.
AMN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 29.37%, AMN perfoms like the industry average, outperforming 58.00% of the companies in the same industry.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
AMN has more shares outstanding than it did 1 year ago.
AMN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
AMN has an Altman-Z score of 2.39. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.39, AMN is in line with its industry, outperforming 54.00% of the companies in the same industry.
AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
AMN's Debt to FCF ratio of 3.80 is fine compared to the rest of the industry. AMN outperforms 72.00% of its industry peers.
A Debt/Equity ratio of 1.31 is on the high side and indicates that AMN has dependencies on debt financing.
The Debt to Equity ratio of AMN (1.31) is worse than 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.26
WACC7.88%
2.3 Liquidity
AMN has a Current Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN has a Current ratio of 1.05. This is in the lower half of the industry: AMN underperforms 69.00% of its industry peers.
A Quick Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
AMN has a worse Quick ratio (1.05) than 62.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -51.29% in the last year.
AMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.80% yearly.
AMN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.42%.
The Revenue has been growing slightly by 6.07% on average over the past years.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
The Revenue is expected to grow by 4.40% on average over the next years.
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AMN is valuated reasonably with a Price/Earnings ratio of 8.22.
AMN's Price/Earnings ratio is rather cheap when compared to the industry. AMN is cheaper than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.25, AMN is valued rather cheaply.
AMN is valuated rather expensively with a Price/Forward Earnings ratio of 20.13.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than the industry average as 62.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AMN to the average of the S&P500 Index (23.98), we can say AMN is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.22 | ||
| Fwd PE | 20.13 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 86.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.68 | ||
| EV/EBITDA | 6.8 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -29.55% in the coming years.
PEG (NY)N/A
PEG (5Y)10.22
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:AMN (1/13/2026, 12:50:40 PM)
15.54
-0.21 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners109.44%
Inst Owner Change0.07%
Ins Owners0.45%
Ins Owner Change2.77%
Market Cap596.89M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.84 (34.11%)
Short Float %6.86%
Short Ratio2.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)-1.38%
PT rev (3m)2.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)39.5%
EPS NY rev (1m)0%
EPS NY rev (3m)20.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.22 | ||
| Fwd PE | 20.13 | ||
| P/S | 0.22 | ||
| P/FCF | 2.68 | ||
| P/OCF | 2.24 | ||
| P/B | 0.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.8 |
EPS(TTM)1.89
EY12.16%
EPS(NY)0.77
Fwd EY4.97%
FCF(TTM)5.8
FCFY37.33%
OCF(TTM)6.94
OCFY44.68%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.22
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.39 |
F-Score4
WACC7.88%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.95%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?
The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -57.99% in the next year.